Pictet Asset Management (UK)’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-14,048
Closed -$3.72M 1048
2019
Q1
$3.72M Buy
14,048
+129
+0.9% +$23.6K 0.01% 759
2018
Q4
$2.78K Sell
13,919
-262
-2% -$79.8K 0.01% 784
2018
Q3
$8.83M Buy
+14,181
New +$6.29M 0.02% 596

Other funds holding TECX

Pictet Asset Management (UK)'s TECX Position: Q2 2019 in Review

Pictet Asset Management (UK) sold out of Tectonic Therapeutic (TECX) in Q2 2019, closing a stake of 14,048 shares — an estimated $3.72M sold.

Pictet Asset Management (UK) first reported a position in TECX in Q3 2018 and held it in 3 quarters. The position peaked at $8.83M in Q3 2018. 66 funds tracked by Wall St. Rank hold TECX as of Q2 2019.

  • Pictet Asset Management (UK) reported no remaining Tectonic Therapeutic position as of Q2 2019 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 14,048 Tectonic Therapeutic shares in Q2 2019, an estimated $3.72M.
  • Pictet Asset Management (UK) first reported a position in Tectonic Therapeutic in Q3 2018 and held it in 3 quarters.
  • Pictet Asset Management (UK)'s Tectonic Therapeutic position peaked at $8.83M in Q3 2018.
  • 66 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2019.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2019, filed 13 Aug 2019.